Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis.

Hiraki Y, Hiraike M, Nagano M, Ozono Y, Manabe K, Misumi N, Tsuji Y, Kamimura H, Karube Y.

Scand J Infect Dis. 2012 Aug;44(8):630-4. doi: 10.3109/00365548.2012.655774. Epub 2012 Feb 19.

PMID:
22339591
2.

Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.

Teigen MM, Duffull S, Dang L, Johnson DW.

J Clin Pharmacol. 2006 Nov;46(11):1259-67.

PMID:
17050791
4.

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.

Clin Infect Dis. 2009 Mar 15;48(6):713-21. doi: 10.1086/597031.

PMID:
19207079
5.
6.

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.

Nace H, Lorber B.

J Antimicrob Chemother. 2010 Jun;65(6):1315-6. doi: 10.1093/jac/dkq113. Epub 2010 Apr 7. No abstract available.

PMID:
20375035
7.

Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.

Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.

Clin Infect Dis. 2009 Sep 1;49(5):691-8. doi: 10.1086/604710.

PMID:
19635023
8.

Gentamicin and vancomycin removal by continuous venovenous hemofiltration.

Thomson AH, Grant AC, Rodger RS, Hughes RL.

DICP. 1991 Feb;25(2):127-9.

PMID:
2058183
9.

Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report.

Saravu K, Mukhopadhyay C, Satyanarayanan V, Pai A, Komaranchath AS, Munim F, Shastry BA, Tom D.

Scand J Infect Dis. 2012 Jul;44(7):544-7. doi: 10.3109/00365548.2012.657233. Epub 2012 Mar 4.

PMID:
22385220
10.

[Treatment of mitral MRSA endocarditis using daptomycin].

Senneville E, Beltrand E, Legout L, Leroy O, Fayad G.

Med Mal Infect. 2008 Dec;38 Spec No 2:13-5. doi: 10.1016/S0399-077X(08)75154-0. French. No abstract available.

PMID:
19185204
12.

Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.

Murray HW, Wigley FM, Mann JJ, Arthur RR.

Arch Intern Med. 1976 Apr;136(4):480-3.

PMID:
1267557
13.

Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.

Sande MA, Courtney KB.

J Lab Clin Med. 1976 Jul;88(1):118-24.

PMID:
1047088
14.

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G.

J Antimicrob Chemother. 2011 Apr;66(4):863-6. doi: 10.1093/jac/dkr019. Epub 2011 Jan 31.

PMID:
21393213
15.

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.

Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A.

Ann Intern Med. 1996 Dec 15;125(12):969-74.

PMID:
8967707
16.

Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.

Xuan D, Nicolau DP, Nightingale CH.

Int J Antimicrob Agents. 2004 Mar;23(3):291-5.

PMID:
15164971
17.

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model.

Jacqueline C, Caillon J, Batard E, Le Mabecque V, Amador G, Ge Y, Biek D, Potel G.

J Antimicrob Chemother. 2010 Oct;65(10):2264-5. doi: 10.1093/jac/dkq328. Epub 2010 Aug 17. No abstract available.

PMID:
20716553
18.

Bayesian pharmacokinetics of gentamicin in a haemodialysis population.

Vercaigne LM, Ariano RE, Zacharias JM.

Clin Pharmacokinet. 2004;43(3):205-10.

PMID:
14871157
19.
20.

Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.

Matsumoto K, Kanazawa N, Ikawa K, Fukamizu T, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K.

J Infect Chemother. 2010 Jun;16(3):193-9. doi: 10.1007/s10156-010-0038-8. Epub 2010 Mar 2.

PMID:
20195882

Supplemental Content

Support Center